Youth with ADHD have increased rates of physical conditions such as asthma and eczema before diagnosis
4 percent increase in risk for CVD seen in association with each one-year increase in ADHD meds across 14 years of follow-up
Findings based on nearly four years of data with in-vehicle recording devices
Solriamfetol found to be well tolerated with no significant effect on mean heart rate, systolic or diastolic BP
Presence of adult ADHD significantly linked to increased dementia risk in unadjusted and adjusted analyses
Significant variance seen by sociodemographic factors
Likelihood of experiencing a serious medical outcome or being admitted to a health care facility was increased for children younger than 6 years
Independent association seen for genetic liability to ADHD with risk for anorexia nervosa; bidirectional link noted to major depressive disorder
Agencies are also asking prescribers to carefully monitor their prescribing practices
<p>No evidence seen for link between childhood stimulant treatment and substance use during adolescence and young adulthood</p>